Humoral immunity in brain aging and Alzheimer's disease

被引:54
作者
Bouras, C
Riederer, BM
Kövari, E
Hof, PR
Giannakopoulos, P
机构
[1] Univ Hosp Geneva, Dept Psychiat, CH-1225 Geneva, Switzerland
[2] Univ Lausanne, Fac Biol & Med, Inst Cell Biol & Morphol, CH-1005 Lausanne, Switzerland
[3] Psychiat Neurosci Ctr, CH-1008 Prilly, Switzerland
[4] Mt Sinai Hosp, Dept Neurosci, New York, NY USA
[5] Mt Sinai Hosp, Dept Geriatr & Adult Dev, New York, NY USA
[6] Serv Old Age Psychiat, CH-1008 Prilly, Switzerland
关键词
brain aging; cytoskeleton; immunoglobulins; microtubules; neurodegeneration; tau;
D O I
10.1016/j.brainresrev.2004.09.009
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Although the contribution of inflammatory processes in the etiology of late-onset Alzheimer's disease (AD) has been suspected for years.. most studies were confined to the analysis of cell-mediated immunological reactions thought to represent an epiphenomenon of AD lesion development. Based on the traditional view of the "immunological privilege" of the brain, which excludes a direct access of human immunoglobulins (Ig) to the central nervous system under normal conditions, little attention has been paid to a possible role of Immoral immunity in AD pathogenesis. In the first part of this review, we summarize evidences for a bloodbrain barrier (BBB) dysfunction in this disorder and critically comment on earlier observations supporting the presence of anti-brain autoantibodies and immunoglobulins (Ig) in AD brains. Current concepts regarding the Ig turnover in the central nervous system and the mechanisms of glial and neuronal Fc receptors activation are also discussed. In the second part, we present new ex vivo and in vitro data suggesting that human immunoglobulins can interact with tau protein and alter both the dynamics and structural organization of microtubules. Subsequent experiments needed to test this new working hypothesis are addressed at the end of the review. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:477 / 487
页数:11
相关论文
共 93 条
[1]
Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]
MICROTUBULE DYNAMICS [J].
AVILA, J .
FASEB JOURNAL, 1990, 4 (15) :3284-3290
[3]
NEURONAL LOSS, NEUROFIBRILLARY TANGLES AND GRANULOVACUOLAR DEGENERATION IN HIPPOCAMPUS WITH AGING AND DEMENTIA - QUANTITATIVE STUDY [J].
BALL, MJ .
ACTA NEUROPATHOLOGICA, 1977, 37 (02) :111-118
[4]
IN-VIVO DEMONSTRATION OF SUBCELLULAR-LOCALIZATION OF ANTITRANSFERRIN RECEPTOR MONOCLONAL ANTIBODY-COLLOIDAL GOLD CONJUGATE IN BRAIN CAPILLARY ENDOTHELIUM [J].
BICKEL, U ;
KANG, YS ;
YOSHIKAWA, T ;
PARDRIDGE, WM .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1994, 42 (11) :1493-1497
[5]
Blennow K, 1990, Eur Neuropsychopharmacol, V1, P79, DOI 10.1016/0924-977X(90)90017-5
[6]
BLENNOW K, 1990, Alzheimer Disease and Associated Disorders, V4, P79, DOI 10.1097/00002093-199040200-00002
[7]
Induction of MC-1 immunoreactivity in axons after injection of the Fc fragment of human immunoglobulins in macaque monkeys [J].
Bouras, C ;
Riederer, BM ;
Hof, PR ;
Giannakopoulos, P .
ACTA NEUROPATHOLOGICA, 2003, 105 (01) :58-64
[8]
ABNORMAL TAU-PHOSPHORYLATION AT SER(396) IN ALZHEIMERS-DISEASE RECAPITULATES DEVELOPMENT AND CONTRIBUTES TO REDUCED MICROTUBULE-BINDING [J].
BRAMBLETT, GT ;
GOEDERT, M ;
JAKES, R ;
MERRICK, SE ;
TROJANOWSKI, JQ ;
LEE, VMY .
NEURON, 1993, 10 (06) :1089-1099
[9]
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders [J].
Buée, L ;
Bussière, T ;
Buée-Scherrer, V ;
Delacourte, A ;
Hof, PR .
BRAIN RESEARCH REVIEWS, 2000, 33 (01) :95-130
[10]
Burgoon MP, 1999, J IMMUNOL, V163, P3496